Skip to main content
SpringerLink
Log in

Interferone bei Erkrankungen der Haut und der angrenzenden Schleimhäute

  • Chapter
Interferone

Zusammenfassung

Für die Dermatotherapie zeichnet sich mit den Interferonen eine ganz neue Entwicklung ab. Es handelt sich um Proteine und Glykoproteine, die im Organismus selbst produziert werden und in niedrigen Konzentrationen wirksam sind. Ihre Aktivität ist weitgehend speziesspezifisch. Damit sind Interferone mit Hormonen vergleichbar. Als körpereigene Proteine stellen sie Komponenten der unspezifischen Abwehr des Organismus gegen Infektionen und Tumoren dar [75].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Androphy EJ, Dvoretzky I, Maluish AE (1984) Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon. J Am Acad Dermatol 11: 197–202

    PubMed  CAS  Google Scholar 

  2. Androphy EJ (1986) Papillomaviruses and interferon. In: Ciba Foundation Symposium 120: Papillomaviruses. Wiley and sons, Chichester, New York, Brisbane, Toronto, Singapore, pp 221–228

    Google Scholar 

  3. Berman B, Jaliman D (1985) The human interferon system. In: Stone J (ed) Dermatologie immunology and allergy. Mosby, St. Louis, pp 899–909

    Google Scholar 

  4. Berthold J, Schöpf E. Völckers W. Brzoska J (1989) Topical application of interferon beta as adjuvant in the treatment of recurrent genital warts: Results of a placebo-controlled double-blind study. J Invest Dermatol 93 (4): 541

    Google Scholar 

  5. Blanchet-Bardon C, Puissant A, Lutzner M, Orth G, Natini MT, Guesry P (1981) Interferon treatment of skin cancer in patients with epidermodysplasia verruciformis. Lancet 1: 274

    PubMed  CAS  Google Scholar 

  6. Bocci V (1985) The physiological interferon response. Immunol Today 6: 7

    CAS  Google Scholar 

  7. Boyle J, Dick DC, Mackie RM (1983) Treatment of extensive virus warts with etretinate ( Tigason) in a patient with sarcoidosis. Clin Exp Dermatol 8: 33–36

    Google Scholar 

  8. Braathen LR, McFadden N (1989) Successful treatment of mycosis fungoides with the combination of etretinate and human recombinant interferon alfa-2a. J Dermatol Treatment 1: 29–32

    Google Scholar 

  9. Bratzke B, Stadler R, Eichhorn R, Ehlers G, Orfanos CE (1987) Disseminiertes mukokutanes Kaposi-Sarkom bei AIDS. Klinische und therapeutische Erfahrungen an 13 Patienten. Hautarzt 38: 286–294

    PubMed  CAS  Google Scholar 

  10. Braun-Falco O, Landthaler M, Hölzle D, Konz B, Schmoeckel C (1986) Therapie und Prognose maligner Melanome der Haut. Dtsch Med Wochenschr 111: 1750–1756

    PubMed  CAS  Google Scholar 

  11. Bretandeau B, Palangie T, Jouve N, Garcia-Giralt E, Mathiot C, Derstepani L, Falcoff E, Schwalb D, Pouillart P (1984) Study of the effect of recombinant leukocyte interferon (Hu IFN Alpha 2) in patients with metastatic malignant melanoma. Bull Cancer 71: 75–76

    Google Scholar 

  12. Bunn PA, Foon KA, Inde DC, Longo DL, Eddy J, Winkler CF, Veach SR, Zeffren J, Sherwin S, Oldham R (1984) Recombinant leukocyte A interferon: an active agent in advanced cutaneous T cell lymphomas. Ann Intern Med 101: 484–487

    PubMed  Google Scholar 

  13. Bunn PA, Foon KA (1985) Therapeutic options in advanced cutaneous T cell lymphomas: a role for interferon alpha 2a (Roferon-A). Semin Oncol 12S5: 18–24

    Google Scholar 

  14. Bunn PA, Ihde DC, Foon KA (1986) The role of recombinant interferon alpha 2a in the therapy of cutaneous T cell lymphomas. Cancer 57: 1689–1695

    PubMed  Google Scholar 

  15. Byrne MA, Möller BR, Taylor-Robinson D, Harris JRW, Wickenden C, Malcolm ADB, Anderson MC, Coleman DV (1986) The effect of interferon on human papillomavirus associated with cervical intraepithelial neoplasia ( CIN ). Br J Obstet Gynecol 93: 1136–1144

    Google Scholar 

  16. Carson LF, Twiggs LB, Fukushima M (1986) Human genital papillomavirus infections: An evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. Am J Obstet Gynecol 155: 784–789

    Google Scholar 

  17. Cauda R, Tyring SK, Grossi CE (1987) Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer cell activity. J Clin Immunol 7: 304–311

    PubMed  CAS  Google Scholar 

  18. Choo YC, Hsu C, Seto WH, Miller DG, Merigan TC, Ng MH, Ma HK (1985) Intravaginal application of leukocyte interferon gel in the treatment of cervical intraepithelial neoplasia ( CIN ). Arch Gynecol 237: 51–54

    Google Scholar 

  19. Choo YC, Seto WH, Hsu C, Merigan TC, Tan YH, Matt K, Ng NH (1986) Cervical intraepithelial neoplasia treated by perilesional injection of interferon. Br. J. Obstet Gynecol 93: 372–379

    Google Scholar 

  20. Coates A, Railings M, Hersey P, Swanson C (1986) Phase II study of recombinant alpha 2-interferon in advanced malignant melanoma. J Interferon Res 6: 1–4

    PubMed  CAS  Google Scholar 

  21. Covelli A, Cavalieri R, Coppola G, de Palo G, de Pita O, Ricciotti L, Simone R, Crisciulo D, Papa G, Mandelli F (1987) Recombinant leukocyte A interferon (IFN-r alpha) as initial therapy in mycosis fungoides (MF) and Sezary Syndrome ( SS ). J Clin Oncol 6: 189

    Google Scholar 

  22. Creagan ET, Ahmann DL, Frytak S, Long HJ, Chang MN, Itri LM (1986) Phase II trials of recombinant leucocyte A interferon in disseminated malignant melanoma: results in 96 patients. Cancer Treat Rep 70: 619–624

    PubMed  CAS  Google Scholar 

  23. Creagan ET, Ahmann DL, Green SJ, Long HJ, Chang MN, Itri LM (1987) Three consecutive phase II studies of recombinant interferon alpha 2A in advanced malignant melanoma. Cancer 59 S: 638–646

    Google Scholar 

  24. Dorval T, Palangie T, Jouve M, Garcia-Giralt E, Israel L, Falcoff E, Schwab D, Pouillart P (1986) Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanomas. Cancer 58: 215–218

    PubMed  CAS  Google Scholar 

  25. Douglas JM, Rogers M, Judson FN (1986) The effect of asymptomatic infection with HTLV-3 on the response of anogenital warts to intralesional treatment with recombinant alpha-2 interferon. J Infect Dis 154: 331–334

    PubMed  Google Scholar 

  26. Edwards L, Levine N, Weidner M, Piepkorn M, Smiles K (1986) Effect of intralesional alpha-2 interferon on actinic keratoses. Arch Dermatol 122: 779–782

    PubMed  CAS  Google Scholar 

  27. Erice A, Jordan MC, Chace BA, Fletcher C, Chinnock BJ, Balfour HH Jr (1987) Gancyclovir treatment of cytomegalovirus diesease in transplant recipients and other immunocompromised hosts. JAMA 257: 3082–3087

    PubMed  CAS  Google Scholar 

  28. Erice A, Chow S, Biron KK, Stanat SC, Balfour HH Jr, Jordan MC (1989) Progressive disease due to gancyclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med 320: 289–293

    PubMed  CAS  Google Scholar 

  29. Eron LJ, Harvey L, Toy C, Santomauro D (1986) Interferon in the prevention of genital herpes recurrence. Antimicrobiol Agents Chemother 30: 608–610

    CAS  Google Scholar 

  30. Eron LJ, Judson FN, Tucker S, Prawer S, Mills J, Murphy K, Hickey M, Rogers M, Flannigan S, Hien N, Katz H, Goldman S, Gottlieb A, Adams K, Barton P, Tanner D, Taylor E, Peets E (1986) Interferon therapy of condylomata acuminata N Engl J Med 315: 1059–1069

    PubMed  CAS  Google Scholar 

  31. Erpenbach K, Derschum W, Wiese H, von Vietsch H (1989) Results of the combined Laser and adjuvant interferon alpha 2b therapy for patients with therapy resistent anogenital condylomata acuminata. In: Gross G (ed) Genital Papillomavirus Infections. Advances in modern Diagnosis and Therapy. Hamburg 2nd-3rd February 1989 (Abstraktbuch)

    Google Scholar 

  32. Ferenczi A, Mitao M, Nagai N, Silverstein SJ, Crum CP (1985) Latent papillomavirus and recurring genital warts. N Engl J Med 313: 784–788

    Google Scholar 

  33. Fierlbeck G, Rassner G (1986) Interferon-y bei Psoriasis arthropathica. Dtsch med Wschr 111: 1313–1316

    PubMed  CAS  Google Scholar 

  34. Fierlbeck G, Rassner G (1987) Treatment of condylomata acuminata with systemically administered recombinant gamma interferon. Z Hautkr 62: 1280–1287

    PubMed  CAS  Google Scholar 

  35. Friedmann RM (1977) Antiviral activity of interferons. Bact Rev 41: 543–551

    Google Scholar 

  36. Friedmann-Kien AE, Eron LJ, Conant M, Growdon W, Badiak H, Bradstreet PW, Fedorczyk D, Trout JR, Plasse TF (1988) Natural interferon alpha for treatment of condylomata acuminata. JAMA 259: 533–538

    Google Scholar 

  37. Gall SA, Hudges CE, Mounts P, Segriti A, Weck PK, Whisnant JK (1986) Efficacy of human lymphoblastoid interferon in the therapy of resistant condylomata acuminata. Obstet Gynecol 67: 643–651

    PubMed  CAS  Google Scholar 

  38. Glezermann M, Cohen V, Morshovitz M, Shoham J, Lunenfeld M, Sarow I, Doerner T, Revel M (1988) Placebo-controlled trial of topical interferon in labial and genital herpes. Lancet ii: 150–152

    Google Scholar 

  39. Green JA, Weiss PN, Yeh TJ, Spruance SL (1985) Immune specific interferon production by peripheral blood mononuclear leucocytes from patients with primary and recurrent orolabial herpes simplex virus infections. J Med Virol 15: 437–443

    Google Scholar 

  40. Greenway HT, Cornwell RC, Tanner DJ, Peets E, Bordin GM, Nagi C (1986) Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol 15: 437–443

    PubMed  CAS  Google Scholar 

  41. Grob JJ, Collet AM, Munoz MH, Bonerandi JJ (1988) Treatment of large basal-cell carcinomas with intralesional interferon alpha-2a. Lancet i: 878–879

    Google Scholar 

  42. Gross G, Pfister H, Hagedorn M, Stahn R (1983) Effect of oral aromatic retinoid (Ro 10-9359) on human papillomavirus-2-induced common warts. Dermatologica 166: 48–53

    PubMed  CAS  Google Scholar 

  43. Gross G, Ikenberg H, Gissmann L (1984) Bowenoid dysplasia in human papillomavirus 16 DNA positive flat condylomas during interferon beta treatment. Lancet 2: 1467–1468

    Google Scholar 

  44. Gross G, Hagedorn M, Ikenberg H, Rufli T, Dahlet C, Grosshans E, Gissmann L (1985) Bowenoid papulosis: presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol 121: 858–863

    PubMed  CAS  Google Scholar 

  45. Gross G, Ikenberg H, Gissmann L, Hagedorn M (1985) Papillomavirus infection of the anogenital region: correlation between histology, clinical picture and virus type. Proposal of a new nomenclature. J Invest Dermatol 85: 147–152

    Google Scholar 

  46. Gross G, Roussaki A, Schöpf E, de Villiers EM, Papendiek U (1986) Successful treatment of condylomata acuminata and bowenoid papulosis with subcutaneous injections of low-dose recombinant interferon-alpha. Arch Dermatol 122: 749–750

    Google Scholar 

  47. Gross G, Ikenberg H, Roussaki A, Drees N, Schöpf E (1986) Systemic treatment of condylomata acuminata with recombinant interferon alpha 2a: low-dose superior to the high-dose regimen. Chemotherapy 32: 537–541

    PubMed  CAS  Google Scholar 

  48. Gross G (1986) Interferon-Therapie von Viruswarzen und Condylomata acuminata. In: Rentschier Immuntherapeutische Informationen 7: Internationale Erfahrungen mit natürlichem ß-Interferon. W. Zuckschwerdt Verlag München, Bern, Wien, San Franzisko, pp. 74–82

    Google Scholar 

  49. Gross G (1988) Lesions of the male and female external genitalia associated with human papillomaviruses. In: Syrjänen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer-Verlag Berlin, Heidelberg, New York, London, Paris, Tokyo, pp. 197–234

    Google Scholar 

  50. Gross G, Ellinger K, Roussaki A, Fuchs PG, Peter HH, Pfister H (1988) Epidermodysplasia verruciformis in a patient with Hodgkin’s disease: Characterization of a new papillomavirus type and interferon treatment. J Invest Dermatol 91: 4348

    Google Scholar 

  51. Gross G, Papendiek U (1989) Recombinant interferon alpha 2c gel given as adjuvant to surgery: a method which leads to complete cure without relapse of genital papillomavirus infections. Arch Derm Res 281 A: 142

    Google Scholar 

  52. Gross G, Roussaki A, Pfister H (1989) Recurrent vulvar Buscke-Löwenstein’s tumor-like condylomata acuminata and Hodgkin’s disease effectively treated with recombinant interferon alpha-2c gel as adjuvant to electrosurgery. In: Fritsch P, Schuler G, Hintner H (eds) Immunodeficiency and skin. Curr Probl Dermatol, Basel Karger, 18: pp 178–184

    Google Scholar 

  53. Gross G, Degen W, Hilgarth M, Kowalzick L, Roussaki A, Rufli T, Schöfer H, Brzoska J (1989) Recombinant interferon gamma in genital warts: results of a multicenter placebo-controlled clinical trial. J Invest Dermatol 93 A: 553

    Google Scholar 

  54. Gross G, Roussaki A (1989) Efficacy of interferons on bowenoid papulosis and other precancerous lesions. J Invest Dermatol 93 A: 553

    Google Scholar 

  55. Haglund S, Lundquist PG, Cantell K, Strander H (1981) Interferon therapy in juvenile laryngeal papillomatosis. Arch Otolaryngol 107: 327–332

    PubMed  CAS  Google Scholar 

  56. Harms G, Zwingenberger K, Chehade AK, Talhari S, Racz P, Monakeh A, Douba U, Näkel L, Naiff RD, Kremsner PG, Feldmeier H, Bienzle U (1989) Effects of intradermal gamma-interferon in cutaneous leishmaniasis. Lancet 1: 1287–1292

    PubMed  CAS  Google Scholar 

  57. Zur Hausen H (1976) Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 78: 1–30

    Google Scholar 

  58. Hersey P, MacDonald M, Hall C, Spurling A, Edwards A, Coates A, McCarthy W Immunological effects of recombinant alpha-2a in patients with disseminated melanoma. Cancer 57: 1666

    Google Scholar 

  59. Hirsch MS, Schooley RT, Cosimi AB, Russell PS, Delmonico FL, Tolkoff-Rubin NE, Herrin JT, Cantell K, Farvell ML, Rota TR, Rubin RH (1983) Effect of interferon-alpha on cytomegalovirus reactivation syndromes in renal transplant recipients. N Engl J Med 308: 1489–1493

    Google Scholar 

  60. Hirsch MS, Schooley RT (1989) Resistance to antiviral drugs: The end of innocence. N Engl J Med 320: 313–314

    Google Scholar 

  61. Hohenleuthner U, Landthaler M, Braun-Falco O, Schmöckel C, Haina D (1988) Condylomata gigantea (Buschke-Löwenstein-Tumor) Behandlung mit dem C02-Laser und Interferon. Dtsch Med Wschr 113: 985–987

    Google Scholar 

  62. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301: 5–8

    PubMed  CAS  Google Scholar 

  63. Hündgen M (1988) Pharmakologie der Interferone -alpha, -beta und -gamma. In: Schmoll HJ, Schöpf E (Hrsg) Lokale und systemische Tumortherapie mit Interferonen. Zuckschwerdt: München, Bern, Wien, San Franzisko, S. 5-16 ( Akt. Immunologie 5 )

    Google Scholar 

  64. Ikenberg H, Gissmann L, Gross G, Grußendorf-Conen EJ, zur Hausen H (1983) Human papillomavirus type 16-related DNA in bowenoid papulosis. Int J Cancer 32: 563–565

    PubMed  CAS  Google Scholar 

  65. Ikic D, Bosnic N, Smerdel S (1975) Double-blind clinical study with human leukocyte interferon in the therapy of condylomata acuminata. Proc Symp Clinical Use of Interferon, Zagreb, pp. 239–243

    Google Scholar 

  66. Ikic D, Kirchmajer V, Maricic Z, Jasic D, Krusic J, Knezevic M, Rode B, Soos E (1981) Application of human leukocyte interferon in patients with carcinoma of the uterine cervix. The Lancet 1: 1027–1030

    CAS  Google Scholar 

  67. Isaacs A, Lindenmann B (1957) Virus interference: The interferon. Proc Roy Soc Lond Biol 147 B: 258

    Google Scholar 

  68. Ishihara K, Hayasaka K, Yamamoto A, Hasegawa F (1983) Clinical responses of patients with malignant skin neoplasia to intralesional treatment with three types of interferons (alpha und beta). In: Kishida T (ed) Interferons. ISIFN: Kyoto Japan, pp 222–227

    Google Scholar 

  69. Jablonska S, Orth G, Jarzabek-Chorzelska M, Rzesa G, Obalek S, Glinski W, Favre M, Croissant O (1979) Epidermodysplasia verruciformis versus disseminated Verrucae. J Invest Dermatol 72: 114–119

    PubMed  CAS  Google Scholar 

  70. Jimbow K, Yamana K, Ishida O, Kawamura M, Ito Y, Maeda K (1987) Evaluation of y-IFN for the treatment of lymphoma and melanoma of the skin by systemic and intralesional administration. J Cancer Chemother 14: 152–158

    CAS  Google Scholar 

  71. Kaplan G, Nusrat A, Sarno EN, Job CK, Mc Elrath J, Porta JA, Nathan CF, Coh ZA (1987) Cellular responses to the intradermal injection of recombinant human y-interferon in lepromatous leprosy patients. Am J Pathol 128: 345–353

    PubMed  CAS  Google Scholar 

  72. Keay S, Teng N, Eisenberg M, Story B, Sellers PW, Merigan TC (1988) Topical interferon for treating condylomata acuminata in women. J Infect Dis 185: 934–939

    Google Scholar 

  73. Keczkes K, Basheer AM (1982) Do corticosteroids prevent postherpetic neuralgia. Br J Dermatol 102: 551–555

    Google Scholar 

  74. Kirby P, Wells D, Kiviat N, Corey L (1986) A phase I trial of intramuscular recombinant human gamma interferon for refractory genital warts. J Invest Dermatol 86: 483

    Google Scholar 

  75. Kirchner H (1986) Das Interferonsystem unter besonderer Berücksichtigung des Gamma-Interferons. Dtsch Med Wochenschr 111: 64–70

    PubMed  CAS  Google Scholar 

  76. Kirkwood JM, Ernstoff M (1986) Potential applications of the interferons in oncology: lesions drawn from studies of human melanoma. Semin Oncol 13 S: 48–56

    Google Scholar 

  77. Krown SE, Real FX, Cunningham-Rundles S, Myskowski PL, Koziner B, Fein S, Mittelman A, Oettgen HF, Safai B (1983) Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi’s sarkoma. N Engl J Med 308: 1071–1076

    PubMed  CAS  Google Scholar 

  78. Krusic J, Ikic D, Knezevic M, Soos E, Rode B, Jusic D, Maricic Z (1972) Clinical and histological findings after local applications of human leukocyte interferon in patients with cervical cancer. Proc Symp Clinical Use of Interferon. 1 Ith Int Immunobiol Symp Yugoslaw Acad Sci Arts. Zagreb, pp. 167–177

    Google Scholar 

  79. Kuhls TL, Sacher J, Weismeier E, Santomauro D, Pineda E, Bryson Y (1985) Double blind study of suppression of recurrent genital HSV infection by recombinant alpha 2 I FN. 25th Intersci. Conf. Antimicrob Agents Chemother, Minneapolis, Minn, p. 106

    Google Scholar 

  80. Kulke R, Gross G, Pfister H (1989) Duplication of enhancer sequences in human papillomavirus 6 from condylomas of the mamilla. J Virol 173: 284–290

    CAS  Google Scholar 

  81. Lassus A, Bergezin I, Paloranta A, Rinne E, Eskelinen A, Säilä K (1987) Efficacy of interferon and placebo in the treatment of recurrent genital herpes: A double-blind trial. Sex Transm Diss 14: 185–190

    Google Scholar 

  82. Lutzner MA, Blanchet-Bardon C, Orth G (1984) Clinical observations, virologic studies and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 835: 18–25

    Google Scholar 

  83. Maral J, Steinberg M, Weil M, Chleg CL, Khagat D, Banzet P, Jacquillat CL (1987) L’interferon leucocytaire alpha 2A humain recombinant dans vingt-deux cas de mela- nome malin metastatique. Presse Med 16: 1031–1034

    PubMed  CAS  Google Scholar 

  84. Marcovici R, Peretz BA, Paldi E (1983) Human fibroblast interferon therapy in patients with condylomata acuminata. Isr J Med Sci 19: 104

    Google Scholar 

  85. Mendelson J, Clecner B, Eiley S (1986) Effect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recurrences. Genit Med 62: 97–101

    CAS  Google Scholar 

  86. Merigan TC, Rand KH, Pollar D (1976) Human leucocyte interferon for the treatment of varicella in children with cancer. N Engl J Med 306: 761–765

    Google Scholar 

  87. Meunier L (1988) Les interferons et dermatologie. Ann Dermatol Venereol 115: 1079–1089

    CAS  Google Scholar 

  88. Miller D (1980) The etiology of nasopharyngeal cancer and its management. In: Shapohay SM and Strong MS (eds) Otolaryngologic clinics of North America. W. B. Saunders Co., New York, pp 467–475

    Google Scholar 

  89. Mitsuayasu RT, Taylor JMG, Glaspy J, Fahey JL (1986) Heterogeneity of epidemic Kaposi’s sarcoma. Implications for therapy. Cancer 57: 1657–1661

    Google Scholar 

  90. Möller BR, Johannesen P, Osther K, Ulmsteen U, Hastrup J, Berg K (1983) Treatment of dysplasia of the cervical epithelium with an interferon gel. J Obstet Gynecol 62: 625–629

    Google Scholar 

  91. Mounts P, Shah KV, Kashima H (1982) Viral etiology of juvenile and adult onset of squamous papilloma of the larynx. Proc Natl Acad Sci USA 79: 5425–5429

    PubMed  CAS  Google Scholar 

  92. Mounts P, Kashima H (1984) Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. Laryngoscope 94: 28–33

    PubMed  CAS  Google Scholar 

  93. Munoz A, Carrasco L, Fresno M (1983) Enhancement of susceptibility of HIV-1 infected cells to natural killer lysis by interferon. J Immunol 131: 783–787

    PubMed  CAS  Google Scholar 

  94. Murray HW (1988) Interferon-gamma, the activated macrophage and host defense against microbial challenge. Ann Intern Med 108: 595–608

    PubMed  CAS  Google Scholar 

  95. Neis KJ, Tesseraux M, Claußen C, Hündgen M, Bastert G (1989) Lokale Therapie cervikaler intraepithelialer Neoplasien mit natürlichem beta-Interferon. Archive of Gynecology 245: 550

    Google Scholar 

  96. Nathan CF, Kaplan G, Lewis WR, Nusrat A, Witmer MD, Sherwin SA, Job CK, Horowitz CR, Steinmann RM, Cohin ZA (1986) Local and systemic effects of intradermal recombinant interferon-y in patients with lepromatous leprosy. N Engl J Med 315: 6–15

    PubMed  CAS  Google Scholar 

  97. Niimura M (1983) Intralesional human fibroblast interferon in common warts. J Dermatol 10: 217–220

    PubMed  CAS  Google Scholar 

  98. Olsen EA, Kelly FF, Vollmer RT, Buddin DA, Weck PK (1989) Comparative study of systemic interferon alpha-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol 20: 1023–1030

    PubMed  CAS  Google Scholar 

  99. Onwubalili JK, Scott GM, Robinson JA (1985) Deficient immune interferon production in tuberculosis. Clin Exp Immunol 59: 405–413

    PubMed  CAS  Google Scholar 

  100. Orth G, Favre M, Breitburd F (1980) Epidermodysplasia verruciformis: a model for the role of papillomaviruses in human cancer. In: Essex M, Todaro G, zur Hausen H (eds) Viruses in naturally occurring cancer. Vol. 7. Cold Spring Harbor Conferences on Cell Proliferation. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, pp 259–282

    Google Scholar 

  101. De Palo G, Stefano B, Rilke F, Ghione M (1984) Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with papillomavirus infection. Int J Tiss Reac VI (6): 523–527

    Google Scholar 

  102. De Palo G, Stefanon B, Rilke F, Pilotti S, Ghione M (1985) Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with viral cytopathic effects. J Reprod Med 30: 404–408

    PubMed  Google Scholar 

  103. Panem S, Check IJ, Henriksen D, Vilcek J (1982) Antibodies to alpha-Interferon in a patient with systemic lupus erythematosus. J Immunol 129: 1–3

    PubMed  CAS  Google Scholar 

  104. Papa G, Covelli A, Ricciotti L, Cavalieri R, Coppola G, de Pita O, Simone R, Crisciuto D, Mandelli F (1987) Recombinant interferon alpha 2a in untreated cutaneous T cell lymphomas. 3rd International Conference on malignant lymphomas. Lugano, 12th June 1987

    Google Scholar 

  105. Passwell JH, Shov R, Shoham J (1986) The enhancing effect of interferon-ß and -y on the killing of leishmania tropica major in human mononuclear phagocytes in vitro. J Immunol 136: 3062–3066

    PubMed  CAS  Google Scholar 

  106. Pazin GJ, Ho M, Haverkos HW, Arwin A, Merigan TC, Cantell K (1982) Effects of interferon-alpha on human warts. J Interferon Res 2: 235–243

    PubMed  CAS  Google Scholar 

  107. Pene J, Rousset F, Briere F et al (1988) IgE production by normal human lymphocytes is induced by IL-4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci USA 85: 6880–6884

    PubMed  CAS  Google Scholar 

  108. Pfister H (1984) Biology and biochemistry of papillomaviruses. Rev Physiol Biochem Pharmacol 99: 111–181

    PubMed  CAS  Google Scholar 

  109. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J (1982) Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 216: 429–431

    PubMed  CAS  Google Scholar 

  110. Real FX, Krown SE (1985) Spontaneous regression of Kaposi’s sarcoma with AIDS. N Engl J Med 313: 1659

    PubMed  CAS  Google Scholar 

  111. Reichmann RC, Bonnez W, Greisberger C, Whithney RJ, Tyring S, Miller L, Krueger GG, Covrath H, Weidner M, Myers M, Dolin R (1986) Treatment of condylomata acuminata with intralesionally administered interferons: a multicenter placebo-controlled trial. Clin Res 34: 531–538

    Google Scholar 

  112. Robinson WA, Mughal TI, Thomas MR, Johnson M, Spiegel RJ (1986) Treatment of metastatic malignant melanoma with recombinant interferon alpha 2. Immunobiology 172: 275–282

    PubMed  CAS  Google Scholar 

  113. Saastamoinen J (1989) Interferon ointment in genital warts of males. In: Gross G (ed) Genital Papillomavirus Infections Advances in modern Diagnosis and Therapy. Hamburg, 2nd–3rd February, 1989 (Abstraktbuch)

    Google Scholar 

  114. Schneider V, Kay S, Lee HM (1983) Immunosuppression as a high risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 27: 220–224

    PubMed  CAS  Google Scholar 

  115. Schneider A, Papendiek U, Gissmann L, de Villiers EM (1987) Interferon treatment of human genital papillomavirus infection: importance of viral type. Int J Cancer 40: 610–614

    Google Scholar 

  116. Schneider A, Kirchmayer R, Wagner D, Schlunck G, Papendiek U (1989) Efficacy trial of topically applied gamma interferon in cervical intraepithelial neoplasia. In: Gross G (ed) Genital Papillomavirus Infections. Advances in modern Diagnosis and Therapy. Hamburg, 2nd–3rd February, 1989 (Abstraktbuch)

    Google Scholar 

  117. Schöfer H, Ochsendorf FR, Helm EB (1987) Treatment of oral „hairy“ leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically) Dermatologica 174: 150–153

    PubMed  Google Scholar 

  118. Schönfeld A, Schattner A, Crespi M, Levavi H, Shoham J, Nitke S, Wallach D, Hahn T, Yarden O, Doerner T (1984) Intramuscular human interferon-beta injections in treatment of condylomata acuminata. Lancet 1: 1038–1041

    PubMed  Google Scholar 

  119. Schönfeld A, Ovadia J, Stein L, Levavi H, Nitke S, Doerner T, Revel M (1987) Treatment of flat facial warts with interferon-beta cream. J Dermatol Surg Oncol 13: 299–301

    Google Scholar 

  120. Shou-Nee S, Fang FS, Yumei W, Fang HL, Xing HY (1987) Serum interferon in lupus erythematosus. Br J Dermatol 117: 155–159

    Google Scholar 

  121. Slotman BJ, Heimerhorst TJM, Wijermans PW, Calarne JJ (1988) Interferon-alpha in treatment of intraepithelial neoplasia of the lower genital tract: a case report. Eur J Obstet Gynecol Reprod Biol 27: 327–333

    PubMed  CAS  Google Scholar 

  122. Souillet G, Rousset F, De Vries JE (1989) Alpha-interferon treatment of patients with hyper-IgE-Syndrome. Lancet 1: 1384

    PubMed  CAS  Google Scholar 

  123. Spradbrow PB, Beardmore GL, Francis J (1983) Virions resembling papillomaviruses in hyperkeratotic lesions from sun-damaged skin. Lancet 1: 189

    PubMed  CAS  Google Scholar 

  124. Stadler R, Muller R, Orfanos CE (1986) Effect of recombinant alpha interferon on DNA synthesis and differentiation of human keratinocytes in vitro. Br J Dermatol 114: 273–277

    PubMed  CAS  Google Scholar 

  125. Stadler R, Bratzke B, Orfanos CE (1987) Therapeutischer Einsatz von Alpha Interferon bei metastasierendem malignen Melanom, disseminiertem Kaposi-Sarkom und schwerem Morbus Behcet. Hautarzt 38: 97–100

    PubMed  CAS  Google Scholar 

  126. Stanwick TL, Campbell DE, Nahmias AJ (1982) Cytotoxic properties of human monocytes - macrophages for human fibroblasts infected with herpes virus: interferon production and augmentation. Cell Immunol 70: 132–140

    PubMed  CAS  Google Scholar 

  127. Steinberg BM, Topp WC, Schneider PS (1983) Laryngeal papillomavirus infection during clinical remission period. N Engl J Med 306: 1261–1264

    Google Scholar 

  128. Strander H, Cantell K (1974) Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo. In: Waymouth C (ed) The production and use of interferon for the treatment and prevention of human virus infections. Rockville. MD Tissue Culture Association, pp 49–56

    Google Scholar 

  129. Sulis E, Floris C, Chessa A, Desogus A, Muggiano A, Tedde A, Turno R (1987) Sequential treatment with interferon and chemotherapy of metastatic malignant melanoma. Total remission of cutaneous and visceral metastasis, but not of cerebral metastasis. Tumori 73: 55–58

    Google Scholar 

  130. Sundmacher R, Cantell K, Neumann-Haelin D (1981) Evaluation of interferon in ocular viral diseases. In: De Maeyer, Galasso, Schellekens (eds) The Biology of the Interferon System. Elsevier/North-Holland, Biomedical Press, Amsterdam pp. 501–504

    Google Scholar 

  131. Thestrup-Pedersen K, Hammer R, Kaltoft K, Sogaard H, Zachariae H (1988) Treatment of mycosis fungoides with recombinant interferon-α2a alone and in combination with etretinate. Br J. Dermatol 118:811–818

    Google Scholar 

  132. Thiele B, Mahrle G, Schuff-Werner P, Ikenberg H, Jppen H (1984) Verrucosis generalisata bei familiärem T-Helferzell-Mangel. Behandlung mit Interferon und Tigason. Z Hautkr 60: 929–937

    Google Scholar 

  133. Thompson DB, Mc Leod RC, Hersey P (1987) Phase I/II tolerability and efficacy of recombinant interferon (Roferon) with Dacarbazine (DTIC) in advanced malignant melanoma (MM). Am Soc Clin Oncol A 219, May 17 – 19, Inc. Atlanta, Georgia

    Google Scholar 

  134. Tiedemann KH, Ernst TM (1988) Kombinationstherapie von rezidivierenden Condylomata acuminata mit Elektrokaustik und Alpha-2-Interferon. Akt Dermatol 14: 200–204

    Google Scholar 

  135. Treuner J, Niethammer D, Dannecker G, Hagemann R, Neef V, Hofschneider PH (1980) Successful treatment of nasopharyngeal carcinoma with interferon. Lancet 1: 817–818

    PubMed  CAS  Google Scholar 

  136. Turek JB, Byrne JC, Lowy CR, Dvoretzky I, Friedman RM, Howley PM (1982) Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus - transformed mouse cells. Proc Nat Acad Sci USA 79: 7914–7918

    PubMed  CAS  Google Scholar 

  137. Uyeno K, Ohtsu A (1982) Interferon treatment of viral warts and some skin diseases. In: Kono R, Vilcek J (eds) The clinical potential of interferon. University of Tokyo Press, Tokyo, pp 149–165

    Google Scholar 

  138. Vance JC, Bart BJ, Hansen RC, Reichmann RC, Mc Ewen C, Hatch KD, Berman B, Tanner DJ (1986) Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol 122: 272–277

    PubMed  CAS  Google Scholar 

  139. Vesterinen E, Meyer B, Cantell K, Purola E (1984) Topical treatment of flat vaginal condyloma with human leukocyte interferon. Obstet Gynecol 64: 535–538

    PubMed  CAS  Google Scholar 

  140. De Villiers EM (1989) Heterogeneity of the human papillomavirus group. J Virology 63: 4898–4903

    PubMed  Google Scholar 

  141. De Virgiliis G, Crippa L, Leopardi O, Rainoldi R, Bozzetti P, Remotti G (1987) The role of beta-interferon in the therapy of female genital viral diseases. Int J Immunol 3: 147–150

    Google Scholar 

  142. Volberding P, Gottlieb M, Rothman J (1983) Therapy of Kaposi’s Sarcoma in AIDS with alpha 2 recombinant interferon. Proc Am Soc Clin Oncol 2: 53

    Google Scholar 

  143. Volberding P, Mitsuayasu RT, Golando JP, Siegel RJ (1987) Treatment of Kaposi sarcoma with interferon alpha-2B (Intron A) Cancer 59 S: 620–625

    Google Scholar 

  144. Wadler S, Einzig A, Dutcher JP, Ciobaun N, Landau L, Wiernik PH (1987) Phase II trial of recombinant alpha 2B-interferon (IFN) and low dose cyclophosphamide (CY) in advanced melanoma and renal cell carcinoma ( RCC ). J Clin Oncol 6: 246–249

    Google Scholar 

  145. Wagner D, Gross G (1988) HPV infection of the cervix uteri: prevalence and age distribution of a sexually transmissible disease in a cancer screening program. In: New Frontiers in Cytology. Goerttler K, Feichter GE, Witte S (eds) Springer Verlag Berlin, Heidelberg, New York, London, Paris, Tokyo, pp 63–70

    Google Scholar 

  146. Weck T, Debra A, Buddin MSN, Whisnant JK (1988) Interferons in the treatment of genital human papillomavirus infections. Am J Med 85 S 2a: 159–164

    Google Scholar 

  147. Wolff JM, Zitelli JH, Rabin BS, Smiles KA, Abell E (1985) Intralesional interferon in the treatment of early mycosis fungoides. J Am Acad Dermatol 13: 604–612

    PubMed  CAS  Google Scholar 

  148. Von Wussow P, Jackschies D, Härtung K, Deichert H (1988) Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol Int 8: 225–230

    Google Scholar 

  149. Ziegler JL (1981) Burkitt’s lymphoma. N Engl J Med 305: 735–744

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Med. Klinik III - Onkologie und Hämatologie, Städtisches Krankenhaus, Dhünnberg 60, D-5090, Leverkusen, Deutschland

    Norbert Niederle

  2. Abteilung Immunologie und Transfusionsmedizin, Medizinische Hochschule Hannover, Konstanty-Gutschow-Str. 8, D-3000, Hannover 61, Deutschland

    Peter von Wussow

  3. Zentrum für Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Konstanty-Gutschow-Str. 8, D-3000, Hannover 61, Deutschland

    Peter von Wussow

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gross, G. (1990). Interferone bei Erkrankungen der Haut und der angrenzenden Schleimhäute. In: Niederle, N., von Wussow, P. (eds) Interferone. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93383-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93383-7_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-93384-4

  • Online ISBN: 978-3-642-93383-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation